These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 17558338)

  • 1. Histologic changes in the breast with menopausal hormone therapy use: correlation with breast density, estrogen receptor, progesterone receptor, and proliferation indices.
    Harvey JA; Santen RJ; Petroni GR; Bovbjerg VE; Smolkin ME; Sheriff FS; Russo J
    Menopause; 2008; 15(1):67-73. PubMed ID: 17558338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mammographic density, response to hormones, and breast cancer risk.
    Boyd NF; Melnichouk O; Martin LJ; Hislop G; Chiarelli AM; Yaffe MJ; Minkin S
    J Clin Oncol; 2011 Aug; 29(22):2985-92. PubMed ID: 21709206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of estrogen receptor alpha and progesterone receptor polymorphisms on the effects of hormone therapy on mammographic density.
    van Duijnhoven FJ; Peeters PH; Warren RM; Bingham SA; Uitterlinden AG; van Noord PA; Monninkhof EM; Grobbee DE; van Gils CH
    Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):462-7. PubMed ID: 16537702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial.
    McTiernan A; Martin CF; Peck JD; Aragaki AK; Chlebowski RT; Pisano ED; Wang CY; Brunner RL; Johnson KC; Manson JE; Lewis CE; Kotchen JM; Hulka BS;
    J Natl Cancer Inst; 2005 Sep; 97(18):1366-76. PubMed ID: 16174858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of short-term estradiol and norethindrone acetate treatment on the breasts of normal postmenopausal women.
    Cheng G; Butler R; Warner M; Gustafsson JÅ; Wilczek B; Landgren BM
    Menopause; 2013 May; 20(5):496-503. PubMed ID: 23615640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Menopausal hormone therapies: their effect on mammographic density and breast cancer risk.
    Santen R
    Gynecol Endocrinol; 2005 Jul; 21 Suppl 1():12-6. PubMed ID: 16112950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormone replacement therapy with estrogen or estrogen plus medroxyprogesterone acetate is associated with increased epithelial proliferation in the normal postmenopausal breast.
    Hofseth LJ; Raafat AM; Osuch JR; Pathak DR; Slomski CA; Haslam SZ
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4559-65. PubMed ID: 10599719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms in genes involved in estrogen and progesterone metabolism and mammographic density changes in women randomized to postmenopausal hormone therapy: results from a pilot study.
    Lord SJ; Mack WJ; Van Den Berg D; Pike MC; Ingles SA; Haiman CA; Wang W; Parisky YR; Hodis HN; Ursin G
    Breast Cancer Res; 2005; 7(3):R336-44. PubMed ID: 15987428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baseline breast tissue characteristics determine the effect of tamoxifen on mammographic density change.
    Gabrielson M; Hammarström M; Bergqvist J; Lång K; Rosendahl AH; Borgquist S; Hellgren R; Czene K; Hall P
    Int J Cancer; 2024 Jul; 155(2):339-351. PubMed ID: 38554131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptosis, proliferation, and sex steroid receptors in postmenopausal endometrium before and during HRT.
    Dahmoun M; Odmark IS; Risberg B; Karlsson MG; Pavlenko T; Bäckström T
    Maturitas; 2004 Oct; 49(2):114-23. PubMed ID: 15474755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aromatase inhibitors and mammographic breast density in postmenopausal women receiving hormone therapy.
    Mousa NA; Crystal P; Wolfman WL; Bedaiwy MA; Casper RF
    Menopause; 2008; 15(5):875-84. PubMed ID: 18480735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pain and increased mammographic density in women receiving hormone replacement therapy: a prospective study.
    McNicholas MM; Heneghan JP; Milner MH; Tunney T; Hourihane JB; MacErlaine DP
    AJR Am J Roentgenol; 1994 Aug; 163(2):311-5. PubMed ID: 8037021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mammographic changes related to different types of hormonal therapies.
    Pongsatha S; Muttarak M; Chaovisitseree S; Luewan S; Panpanit A
    J Med Assoc Thai; 2006 Feb; 89(2):123-9. PubMed ID: 16578996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of mammographic density with the proliferation marker Ki-67 in a cohort of patients with invasive breast cancer.
    Heusinger K; Jud SM; Häberle L; Hack CC; Fasching PA; Meier-Meitinger M; Lux MP; Hagenbeck C; Loehberg CR; Wittenberg T; Rauh C; Wagner F; Uder M; Hartmann A; Schulz-Wendtland R; Beckmann MW; Wachter DL
    Breast Cancer Res Treat; 2012 Oct; 135(3):885-92. PubMed ID: 22936391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast density changes associated with postmenopausal hormone therapy: post hoc radiologist- and computer-based analyses.
    Nielsen M; Pettersen PC; Alexandersen P; Karemore G; Raundahl J; Loog M; Christiansen C
    Menopause; 2010 Jul; 17(4):772-8. PubMed ID: 20386343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A mammographic evaluation of the morphostructural variations of the breast during hormone-replacement therapy in the postmenopause].
    Porfiri LM; Costanza L; De Felice C; Perrone G; David V; Zichella L
    Radiol Med; 1998 Jun; 95(6):573-6. PubMed ID: 9717537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women.
    Tamimi RM; Byrne C; Colditz GA; Hankinson SE
    J Natl Cancer Inst; 2007 Aug; 99(15):1178-87. PubMed ID: 17652278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions between body mass index and hormone therapy and postmenopausal breast cancer risk (United States).
    Li CI; Malone KE; Daling JR
    Cancer Causes Control; 2006 Jun; 17(5):695-703. PubMed ID: 16633917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Bazedoxifene and Conjugated Estrogen (Duavee) on Breast Cancer Risk Biomarkers in High-Risk Women: A Pilot Study.
    Fabian CJ; Nye L; Powers KR; Nydegger JL; Kreutzjans AL; Phillips TA; Metheny T; Winblad O; Zalles CM; Hagan CR; Goodman ML; Gajewski BJ; Koestler DC; Chalise P; Kimler BF
    Cancer Prev Res (Phila); 2019 Oct; 12(10):711-720. PubMed ID: 31420361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of mammographic breast density with menopausal status and postmenopausal hormone use in relation to the risk of aggressive breast cancer subtypes.
    Yaghjyan L; Tamimi RM; Bertrand KA; Scott CG; Jensen MR; Pankratz VS; Brandt K; Visscher D; Norman A; Couch F; Shepherd J; Fan B; Chen YY; Ma L; Beck AH; Cummings SR; Kerlikowske K; Vachon CM
    Breast Cancer Res Treat; 2017 Sep; 165(2):421-431. PubMed ID: 28624977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.